Allegria Therapeutics
ID: 17664534Allegria Therapeutics is a therapeutics developer for mast cell-mediated diseases founded in 2023.
1
Funding Rounds
$3.5m
Money raised
Recent Funding Rounds
Overview
Allegria Therapeutics is a therapeutics developer for mast cell-mediated diseases founded in 2023.
- Website:
- Headquarters: Basel
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Allegria Therapeutics has raised a total of $3.5m in funding over 1 rounds.
Key Insights:
- Allegria Therapeutics May 2024 Seed Funding Round: $3.5m
Industries
Allegria Therapeutics is active in the following industries: